Gemeiner M, Pilz I, Swoboda W
Wien Med Wochenschr. 1979 May 15;129(9):237-40.
The efficiency of a daily vitamin D prophylaxis with tablets ("Laevovit D3"), containing 1000 I.U. cholecalciferol was studied in newborn babies (most of them "prematures") over a period of about 5 weeks. The blood-values of 25-hydroxycholecalciferol were taken as parameter and determined 1 week and 5 weeks after the start of vitamin D prophylaxis. The data obtained were--with very few exceptions-- in a range considered to be protective against development of vitamin D deficiency. No significant difference could be found comparing vitamin D prophylaxis with these "microtablets" vs. liquid vitamin D preparations.
对含1000国际单位胆钙化醇的片剂(“维生素D3左型”)用于新生儿(大多数为“早产儿”)进行每日维生素D预防的效果进行了约5周的研究。以25-羟胆钙化醇的血液值作为参数,并在维生素D预防开始后1周和5周进行测定。所获得的数据——极少数例外情况除外——处于被认为可预防维生素D缺乏症发生的范围内。比较使用这些“微型片剂”进行维生素D预防与液体维生素D制剂,未发现显著差异。